EnteroMedics to Present at the 29th Annual Canaccord Adams Global Growth Conference
ST. PAUL, Minn.--(BUSINESS WIRE)--EnteroMedics Inc. (NASDAQ: ETRM) announced today that Mark B. Knudson, Ph.D., Chief Executive Officer, is scheduled to present at the Canaccord Adams' 29th Annual Global Growth Conference in Boston, MA on Tuesday, August 11th at 9:00 am ET. Dr. Knudson will provide an overview of the Company and an update on its VBLOCTM vagal blocking therapy development program.